Effects of C-1311 on Cancer Cells
Author Information
Author(s): J Lamb, DN Wheatley
Primary Institution: University Medical School, Foresterhill, Aberdeen, UK
Hypothesis
Does the imidazoacridinone C-1311 induce cell death in cancer cells through specific cell cycle perturbations?
Conclusion
High doses of C-1311 do not necessarily lead to increased cell death, highlighting the importance of the G2/M transition in the cell death process.
Supporting Evidence
- C-1311 induced a complete G2 arrest in HeLa cells at specific concentrations.
- High doses of C-1311 led to S-phase accumulation, which inhibited cell death.
- Cell death was associated with activation of the p34cdc2/cyclin B complex.
Takeaway
C-1311 is a drug that can stop cancer cells from growing, but too much of it can actually protect the cells instead of killing them.
Methodology
HeLa S3 cells were treated with varying concentrations of C-1311, and cell cycle effects were analyzed using flow cytometry and growth inhibition assays.
Limitations
The study primarily focused on HeLa cells, which may not represent all cancer types.
Participant Demographics
HeLa S3 cells (human cervical cancer cells) and normal human diploid fibroblasts.
Statistical Information
P-Value
0.018+0.003
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website